Back to Trades
Total Value
$58.9K
Filing Date
Jul 10, 2026
1 transactions
Trade Summary
On Jul 8, 2026, Campbell David Alan, Insider, reported $58.9K of Janux Therapeutics, Inc. (JANX) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $4.21. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Janux Therapeutics, Inc.
- Ticker Symbol
- JANX
- CIK
- 0001817713
Insider Information
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001864158-26-000004
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 7,000 | $4.21 | Exercise | $29.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | JANX derivative | 7,000 | $4.21 | Exercise | $29.5K |
Want live alerts when Campbell David Alan trades again?
Download Insider Trades to track JANX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Immediately exercisable.